🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In a recent study (May 2025) published in Nature Genetics, Nomura et al.(Roel Verhaak , Lavarone, Mario Suva , Tirosh Lab labs) leveraged single-nucleus RNA sequencing and bulk tumor DNA sequencing to unveil new dimensions of GBM complexity. The team discovered three previously

Multimodal analyses help understand cell-type gene regulation for early neuronal electrophysiology & autism. An interdisciplinary journey Waisman Center since pandemic from raw data to machine learning to experimental validation! waisman.wisc.edu/2025/05/22/gen…

Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy: Cell cell.com/cell/fulltext/…

Join us for the 2025 Bay Area Cardiovascular Symposium on August 14-15, 2025 10 AM – 5 PM, Berg Hall, Li Ka Shing Center More Info & Registration: tinyurl.com/CVRS2025 Partnering with Stanford University, Gladstone Institutes, San José State University, UC Davis, and UC San Francisco.

New JAK inhibitor drugs successfully treated a patient w/ acute myocarditis, UCSF researchers report in Circulation. “The team is hopeful that these early results can lead to an eventual (clinical) trial for patients,” Dr. Javid Moslehi Javid Moslehi says. ucsfh.org/453bbib

Computational Approaches to Mapping Cells, Tissues, and Tumor Progression: Where Does AI Help? #AACRFellows Dana Pe’er addressed this question in a keynote lecture to open the AACR Special Conference on Artificial Intelligence and Machine Learning. #AACRai25 dana_peer

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets dlvr.it/TLyB5j

Tumor neutrophils rewired from birth dlvr.it/TLyyhp

Are you currently in the ERE related field and want to find new collaborative opportunities? Join our Chairs Kate Chiappinelli @chiappinellilab.bsky.social, Hui Shen, Ting Wang & Tao Wu at the upcoming Endogenous Retrotransposable Elements & Human Diseases Conference this November! #EREHD25 🎙️Talk

Many thanks to Tuomas Tammela lab for their review of our Cancer Cell paper on subclonal immune evasion in Science and Innovation at Cancer Research UK TRACERx cell.com/cancer-cell/ab…

Cancer doesn’t come with a glossary—so we made one. Cancer Decoded is our weekly Instagram series that explains complex cancer terms in plain language. Learn how it’s helping people feel more informed, one post at a time: ow.ly/y8n850W5B59.

Tenure-track faculty positions in Molecular Genetics and Genome Sciences in the University of Oklahoma College of Medicine. Come Join us! medicine.ouhsc.edu/academic-depar… #OUHSC OU College of Medicine ASHG University of Oklahoma

Predicting the translation efficiency of messenger RNA in mammalian cells go.nature.com/4mgXR0C

Viewpoint: The rise of social media and #AI in oncology has transformed scientific communication but also fuels bias, misinterpretation, and financial conflicts of interest. ja.ma/3UrqGLH Raffaele Giusti

New online! Towards improved fine-mapping of candidate causal variants bit.ly/474ZgCN

A new Cell paper is online from brilliant CDSLers! This paper presents the Cancer Immunology Data Engine (CIDE) framework, broadly applicable to #CancerResearch and #Oncology. AOAH is featured as a promising new #Immunotherapy. doi.org/10.1016/j.cell…

Manipulation of the nucleotide pool in human, bacterial and plant immunity bit.ly/4o2Cth4

🚨Don't miss the July issue of Nature Cancer! Check it out here: 🔗nature.com/natcancer/volu… Featuring: ⭐️Review on clonal hematopoiesis in cancer ⭐️Review on CAR engineering for cancer therapy ⭐️immunotherapy ⭐️AI for tumour classification ⭐️single-cell analyses in B-ALL

One in 4 people carry one copy of the APOE4 allele, the strongest known genetic risk factor for Alzheimer's disease. We've just learned how that risk is mediated—the immune system erictopol.substack.com/p/our-brainimm…

Nearly half of patients referred for CAR-T therapy at an academic center did not receive it, influenced by factors like rapid disease progression, lack of appropriate therapies, racial disparities, and logistical challenges. ja.ma/3TWGJ44 Roni Shouval